← Research library

MOTS-c and insulin sensitivity in mouse metabolic experiments

Animal research · 2015

What was studied
Mouse metabolic experiments and cell assays. Glucose tolerance n=7 and insulin clamp n=6–8 as reported in Figure 5.
Main finding
MOTS-c improved glucose tolerance and insulin-stimulated glucose disposal in mice. Hepatic glucose production during the clamp did not show a significant treatment difference.

Reported findings and study design

Vehicle-controlled metabolic testing in mice, including glucose tolerance (n=7) and insulin clamp (n=6–8).

Population or model Mouse metabolic experiments and cell assays. Glucose tolerance n=7 and insulin clamp n=6–8 as reported in Figure 5.

Dose, route and schedule

5 mg/kg/day intraperitoneally for seven days in glucose tolerance and insulin-clamp experiments. Separate diet-induced obesity experiments used 0.5 mg/kg/day intraperitoneally.

Protocol source ↗ · Original Figure 5–6 captions.

Results · Original report and indexed figure captions.
MeasureResultComparison, timing and statistics
Glucose tolerance and insulin-stimulated disposalImproved in mice receiving MOTS-c.After 7 days of 5 mg/kg/day intraperitoneally
Hepatic glucose production during insulin clampNo significant between-group difference reported.
High-fat diet body weight and insulin resistanceBoth reduced with MOTS-c in the prevention experiment.

Source for these results ↗ · Reviewed 2026-11-14

Study limitations and source details

Study limitations

  • These are separate mouse and cell experiments. There was no human dosing arm.

Source details

Original abstract and published Figure 5–6 captions; effect sizes were not digitized.

Sources checked

Citation

Animal / experimentalFull text available

C. Lee, J. Zeng, B. G. Drew, et al.. MOTS-c and insulin sensitivity in mouse metabolic experiments Cell Metab. 2015;21(3):443–454.

Study source ↗ · DOI 10.1016/j.cmet.2015.02.009 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards